BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 31578346)

  • 1. Understanding the Mechanistic Contribution of Herbal Extracts in Compound Kushen Injection With Transcriptome Analysis.
    Shen H; Qu Z; Harata-Lee Y; Aung TN; Cui J; Wang W; Kortschak RD; Adelson DL
    Front Oncol; 2019; 9():632. PubMed ID: 31380274
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Integrated bioinformatics analysis to decipher molecular mechanism of compound Kushen injection for esophageal cancer by combining WGCNA with network pharmacology.
    Zhou W; Wu J; Zhang J; Liu X; Guo S; Jia S; Zhang X; Zhu Y; Wang M
    Sci Rep; 2020 Jul; 10(1):12745. PubMed ID: 32728182
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Network Pharmacology-Based Study on the Molecular Biological Mechanism of Action for Compound Kushen Injection in Anti-Cancer Effect.
    He R; Ou S; Chen S; Ding S
    Med Sci Monit; 2020 Jan; 26():e918520. PubMed ID: 31892693
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Compound kushen injection relieves tumor-associated macrophage-mediated immunosuppression through TNFR1 and sensitizes hepatocellular carcinoma to sorafenib.
    Yang Y; Sun M; Yao W; Wang F; Li X; Wang W; Li J; Gao Z; Qiu L; You R; Yang C; Ba Q; Wang H
    J Immunother Cancer; 2020 Mar; 8(1):. PubMed ID: 32179631
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Study on the mechanisms of compound Kushen injection for the treatment of gastric cancer based on network pharmacology.
    Zhou W; Wu J; Zhu Y; Meng Z; Liu X; Liu S; Ni M; Jia S; Zhang J; Guo S
    BMC Complement Med Ther; 2020 Jan; 20(1):6. PubMed ID: 32020871
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Compound kushen injection for multiple myeloma: A protocol of systematic review and meta-analysis.
    Yang X; Zhao X; Wang X
    Medicine (Baltimore); 2019 Dec; 98(50):e18257. PubMed ID: 31852094
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Compound Kushen Injection for gastric cancer: A protocol of systematic review and meta-analysis.
    Huang Z; Wei P
    Medicine (Baltimore); 2019 Nov; 98(45):e17927. PubMed ID: 31702676
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sub-Cellular Dynamic Analysis of BGC823 Cells after Treatment with the Multi-Component Drug CKI Using Raman Spectroscopy.
    Shang W; Ye A; Tong YK
    Int J Mol Sci; 2023 Aug; 24(16):. PubMed ID: 37628931
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Single-cell RNA-sequencing uncovers compound kushen injection synergistically improves the efficacy of chemotherapy by modulating the tumor environment of breast cancer.
    Liu X; Bai M; Li H; Ye P; Duan X; Wu C; Huang Z; Lu S; Zhang J; Zhao Z; Guo F; You R; Qin W; Wang W; Han A; Shen L; Wang Y; Zhao Z; Luo H; Wu J
    Front Immunol; 2022; 13():965342. PubMed ID: 36389835
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Compound Kushen injection reduces severity of radiation-induced gastrointestinal mucositis in rats.
    Harata-Lee Y; Qu Z; Bateman E; Xiao X; Keller MD; Bowen J; Wang W; Adelson DL
    Front Oncol; 2022; 12():929735. PubMed ID: 36033515
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aquaporin ion conductance properties defined by membrane environment, protein structure, and cell physiology.
    Henderson SW; Nourmohammadi S; Ramesh SA; Yool AJ
    Biophys Rev; 2022 Feb; 14(1):181-198. PubMed ID: 35340612
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cell cycle arrest is an important mechanism of action of compound Kushen injection in the prevention of colorectal cancer.
    Sun J; Li M; Lin T; Wang D; Chen J; Zhang Y; Mu Q; Su H; Wu N; Liu A; Yu Y; Liu Y; Wang S; Yu X; Guo J; Yu W
    Sci Rep; 2022 Mar; 12(1):4384. PubMed ID: 35288618
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An advanced network pharmacology study to explore the novel molecular mechanism of Compound Kushen Injection for treating hepatocellular carcinoma by bioinformatics and experimental verification.
    Lu S; Meng Z; Tan Y; Wu C; Huang Z; Huang J; Fu C; Stalin A; Guo S; Liu X; You L; Li X; Zhang J; Zhou W; Zhang X; Wang M; Wu J
    BMC Complement Med Ther; 2022 Mar; 22(1):54. PubMed ID: 35236335
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High Throughput Transcriptome Data Analysis and Computational Verification Reveal Immunotherapy Biomarkers of Compound Kushen Injection for Treating Triple-Negative Breast Cancer.
    Liu X; Wu Y; Zhang Y; Bu D; Wu C; Lu S; Huang Z; Song Y; Zhao Y; Guo F; Ye P; Fu C; Shen L; Zhang J; Wang H; Duan X; Wu J
    Front Oncol; 2021; 11():747300. PubMed ID: 34604090
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of Compound Kushen Injection, a Natural Compound Mixture, and Its Identified Chemical Components on Migration and Invasion of Colon, Brain, and Breast Cancer Cell Lines.
    Nourmohammadi S; Aung TN; Cui J; Pei JV; De Ieso ML; Harata-Lee Y; Qu Z; Adelson DL; Yool AJ
    Front Oncol; 2019; 9():314. PubMed ID: 31106149
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fractional Deletion of Compound Kushen Injection Indicates Cytokine Signaling Pathways are Critical for its Perturbation of the Cell Cycle.
    Aung TN; Nourmohammadi S; Qu Z; Harata-Lee Y; Cui J; Shen HY; Yool AJ; Pukala T; Du H; Kortschak RD; Wei W; Adelson DL
    Sci Rep; 2019 Oct; 9(1):14200. PubMed ID: 31578346
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of compound kushen injection on cancer cells: Integrated identification of candidate molecular mechanisms.
    Cui J; Qu Z; Harata-Lee Y; Shen H; Aung TN; Wang W; Kortschak RD; Adelson DL
    PLoS One; 2020; 15(7):e0236395. PubMed ID: 32730293
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.